Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 127-133

  Lv, Wuwen ^a   Yang, Tongshu ^b  

^a HARBIN UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Breast cancer; Free fatty acids; Gas chromatography mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FATTY ACID; LINOLEIC ACID; PALMITIC ACID; SATURATED FATTY ACID; STEARIC ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CALIBRATION; CASE-CONTROL STUDIES; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, UNSATURATED; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855333543     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.10.011     Document Type: Article

References (41)

1. Benson J.R., Jatoi I., Keisch M., Esteva F.J., Makris A., Jordan V.C. Early breast cancer. Lancet 2009, 373:1463-1479.
2. Ely S., Vioral A.N. Breast cancer overview. Plast Surg Nurs 2007, 27:128-133.
3. Claudino W.M., Quattrone A., Biganzoli L., Pestrin M., Bertini I., Di Leo A. Metabolomics: available results, current research projects in breast cancer and future applications. J Clin Oncol 2007, 25:2840-2846.
4. Wikoff W.R., Gangoiti J.A., Barsho B.A.p, Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 2007, 53:2169-2176.
5. Xue R., Lin Z., Deng C., Dong L., Liu T., Wang J., et al. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Mass Spectrom 2008, 22:3061-3068.
6. Bogdanov M., Matson W.R., Wang L., Matson T., Saunders-Pullman R., Bressman S.S., et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 2008, 131:389-396.
7. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002, 1:153-161.
8. Jonsson P., Gullberg J., Nordstrom A., Kusano M., Kowalczyk M., Sjostrom M., et al. A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal Chem 2004, 76:1738-1745.
9. Jonsson P., Johansson A.I., Gullberg J., Trygg J., Jiye A., Grung B., et al. Highthroughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem 2005, 77:5635-5642.
10. Deng C., Zhang J., Yu X., Zhang W., Zhang X. Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. J Chromatogr B 2004, 810:269-275.
11. Yang J., Xu G.W. Discrimination of diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J Chromatogr B 2004, 813:53-58.
12. Liu L.Y., Li Y., Guan C.M., Li K., Wang C., Feng R.N., et al. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B 2010, 878:2817-2825.
13. Nam H.J., Chung B.C., Kim Y.H., Lee K.Y., Lee D. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics 2009, 25:3151-3157.
14. Kim Y., Koo I., Jung B.H., Chung B.C., Lee D. Multivariate classification of urine metabolome profiles for breast cancer diagnosis. Bioinformatics 2010, 11:S4.
15. Bathen T.F., Jensen L.R., Sitter B., Fjosne H.E., Halgunset J., Axelson D.E., et al. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 2007, 104:181-189.
16. Vatten L.J., Bjerve K.S. Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case-control study from the Janus serum bank in Norway. Eur J Cancer 1993, 29:532-538.
17. Punnonen K., Hietanen E., Auvinen O., Punnonen R. Phospholipids and fatty acids in breast cancer tissue. J Cancer Res Clin Oncol 1989, 115:575-578.
18. Singletary S.E., Allred C., Ashley P. Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 2002, 20:3628-3636.
19. Barker M., Rayens W. Partial least squares for discrimination. J Chemom 2003, 17:166-173.
20. Eriksson L., Johansson E., Kettaneh-Wold N. Multi- and megavariate data analysis-part 1: basic principles and applications 2001.
21. Pohjanen E., Thysell E., Lindberg J., Schuppe-Koistinen I., Moritz T., Jonsson P., et al. Statistical multivariate metabolite profiling for aiding biomarker pattern detection and mechanistic interpretations in GC/MS based metabolomics. Metabolomics 2006, 2:257-268.
22. Hastie T., Tibshirani R., Friedman J. The elements of statistical learning: data mining, inference, and prediction 2009.
23. Eriksson L, Johansson E, Kettanah-Wold N, Wold S. Umetrics AB, Malmo, Sweden. 1999.
24. User's Guide to SIMCA-P, SIMCA-P+ version 11.0, Umetrics AB, Ume, 2000.
25. Molina R., Zanon G., Filella X., et al. Use of serial carcinoembryonic antigen and CA15. 3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 1995, 36:41-48.
26. Ballesta A.M., Molina R., Filella X., et al. Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol 1995, 16:32-41.
27. Nicolini A., Ferrari P., Sagripanti A., Carpi A. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy. Br J Cancer 1999, 79:1443-1447.
28. Berruti A., Tampellini M., Torta M., et al. Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. Eur J Cancer 1994, 30A:2082-2084.
29. Staessena L., De Henauw S., De Bacquer D., De Backer G., Van Peteghem C. Consumption of fatty acids in Belgium and its relationship with cancer mortality. Cancer Lett 1997, 114:109-111.
30. Howe G.R., Hirohata T., Hislop T.G. Dietary factors and risk of breast cancer; combined analysis of 12 case control studies. J Natl Cancer Inst 1990, 82:561-569.
31. Murff H.J., Shu X.O., Li H.L., Yang G., Wu X.Y., Cai H., et al. Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. Int J Cancer 2011, 128:1434-1441.
32. Greenwald P. Role of dietary fat in the causation of breast cancer: point. Cancer Epidemiol Biomarkers Prev 1999, 8:3-7.
33. Nkondjock A., Shatenstein B., Ghadirian P. A case-control study of breast cancer and dietary intake of individual fatty acids and antioxidants in Montreal, Canada. Breast 2003, 12:131-138.
34. Dhaval S.F. Significance of alterations in plasma lipid profile levels in breast cancer. Integr Cancer Ther 2008, 7:33-41.
35. Ruddock M.W., Stein A., Landaker E., Robert C. Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling. J Biochem 2008, 144:599-607.
36. Shannon J., King B.I., Moshofsky R., Lampe J.W., Gao D.L., Ray R.M., et al. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr 2007, 85:1090-1097.
37. Kachhap S.K., Dange P., Nath Ghosh S. Effect of omega-6 polyunsaturated fatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line. Cancer Lett 2000, 154:115-120.
38. Rose D.P., Connolly J.M. Omega-3 fattyacids as cancer chemopreventive agents. Pharmacol Ther 1999, 83:217-244.
39. Abu-Bedair F.A., El-Gamal B.A., Ibrahim N.A., El-Aaser A.A. Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol 2003, 33:278-282.
40. Am F., Branchi A., Sommaviva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 2000, 30:141-145.
41. Takata Y., King I.B., Schaffer S., Barnett M., Thornquist M., Peters U., et al. Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers. Cancer Causes Control 2009, 20:497-504.